Strategic partnerships Clip Health has a history of collaboration with other organizations (example: Curebase in decentralized studies) and recently sold assets to Gold Colloid. Potential sales opportunity: position complementary diagnostic and data integration solutions for ongoing or new at-home testing programs and cross-sell with partners in clinical research and health-tech ecosystems.

At-home testing The company focuses on at-home, point-of-care, and enterprise settings for actionable health testing. Sales opportunities include scalable home-testing kits, connected hardware with remote monitoring, and software platforms that integrate with existing EHRs to improve accessibility and follow-up care.

Full-stack diagnostics Clip Health aims for a diagnostics-enabled full-stack healthcare model. This alignment suggests opportunities to offer end-to-end solutions, including assay development, QA/regulatory support, and continuous product improvement services to accelerate new test launches.

Health-tech stack Current tech usage includes cloud services, HIPAA compliance, Raspberry Pi based hardware, and web analytics. Potential upsell: secure data management, interoperability modules, and device integration services that enhance reliability, security, and patient data privacy.

Growth readiness With revenue in the low millions and a funding base of significant size, Clip Health is positioned for expansion but remains lean (11-50 employees). Opportunities exist for enterprise-grade deployments, channel partnerships, and scaled support when pursuing larger health systems or payer-backed programs.